Wells Fargo Says These 2 Stocks Are Worth Buying Now — Here’s Why
For much of the past several years, some of the market’s biggest gains have come from a relatively narrow group of mega-cap tech stocks. That pictu...
Ptc Therapeutics Inc. (PTCT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squarepoint Ops LLC Maxime Fortin (Cio) | 282,789 | $18,319,071 | 0.02% | |
| 2. | Fisher Asset Management Ken Fisher | 43,083 | $2,790,915 | +6% | 0% |
| 3. | Royce & Associates Chuck Royce | 6,046 | $391,660 | -37% | 0% |
| 4. | Bayforest Capital Theodoros Tsagaris | 454 | $29,410 | -25% | 0.04% |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.81 | 7,700 | $198,736.23 | 33,700 | 2023-12-12 | Filing | |
| $32.48 | 10,000 | $324,846.00 | 100,066 | 2020-03-16 | Filing | |
| $30.20 | 66,225 | $1,999,995.00 | 1,386,594 | 2019-01-25 | Filing | |
| $13.49 | 25,000 | $337,230.00 | 25,000 | 2017-05-23 | Filing | |
| $6.23 | 2,000 | $12,460.00 | 5,125 | 2016-03-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.14 | 382 | $22,973.48 | 1,291,594 | 2026-10-14 | Filing | |
| $59.52 | 2,118 | $126,063.36 | 1,291,976 | 2026-10-14 | Filing | |
| $64.26 | 192 | $12,337.92 | 105,272 | 2026-10-09 | Filing | |
| $63.95 | 53 | $3,389.35 | 1,294,094 | 2026-10-07 | Filing | |
| $63.38 | 2,447 | $155,090.86 | 1,294,147 | 2026-10-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,147,988 | $139,173,677 | 0.01% | |
| 2. | 1,880,447 | $121,815,357 | 0.02% | |
| 3. | 1,693,624 | $109,712,963 | 0.36% | |
| 4. | 1,217,460 | $78,867,058 | 0% | |
| 5. | 863,454 | $55,931,116 | 0.05% |
News See All
Measuring the Beat: 57 Stocks Surpassing Earnings Expectations
Academic research has consistently found that corporate earnings surprises cluster around small positive values, rather than large outperformance.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2026 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2026 Earnings Call Transcript May 8, 2026 Operator: Ladies and gentlemen, thank you for standing by.
PTC Therapeutics (PTCT) Reports Positive Huntington’s Disease Trial Results
PTC Therapeutics, Inc. (NASDAQ:PTCT) ranks among the most profitable biotech stocks to buy now. On April 28, PTC Therapeutics, Inc.
10 Most Profitable Biotech Stocks to Buy Now
In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Ladies and gentlemen, thank you for standing by.
Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves
We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. PTC Therapeutics, Inc. is among the best high growth stocks.
15 High Growth Mid-Cap Stocks to Buy
In this article, we will be taking a look at the 15 High Growth Mid-cap Stocks to Buy.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2025 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2025 Earnings Call Transcript November 5, 2025 Operator: Ladies and gentlemen, thank you for standing by.
Bank of America Securities Lifts PT on PTC Therapeutics (PTCT) to $87 From $76
PTC Therapeutics, Inc. (NASDAQ:PTCT) is one of the most profitable biotech stocks to buy.
Hedge Fund Resource Center